pharma · Metastatic Solid Tumor · Advanced or Metastatic Solid Tumors · HOWL
Werewolf Therapeutics
Werewolf Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.
Company details
- Status
- Public
- HQ
- Milton, GB
- Founded
- 2017
- Employees
- 53
- Programs
- 2
- Drugs
- 0
- Patents
- 10
Werewolf Therapeutics pipeline
Portfolio lens on 0 drugs and development assets — regulatory status, targets, and deep links to NovaPharmaNews drug profiles.
Werewolf Therapeutics drug portfolio — 0 indexed compounds with therapeutic class and molecular targets from public FDA and regional approval metadata.